These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16781151)

  • 21. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
    Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
    Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferulic acid and benzothiazole dimer derivatives with high binding affinity to beta-amyloid fibrils.
    Byeon SR; Jin YJ; Lim SJ; Lee JH; Yoo KH; Shin KJ; Oh SJ; Kim DJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4022-5. PubMed ID: 17544669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.
    Marques AT; Fernandes PA; Ramos MJ
    Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation.
    Crouch PJ; Tew DJ; Du T; Nguyen DN; Caragounis A; Filiz G; Blake RE; Trounce IA; Soon CP; Laughton K; Perez KA; Li QX; Cherny RA; Masters CL; Barnham KJ; White AR
    J Neurochem; 2009 Mar; 108(5):1198-207. PubMed ID: 19141082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
    Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H
    Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with beta-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation.
    Juszczyk P; Paraschiv G; Szymanska A; Kolodziejczyk AS; Rodziewicz-Motowidlo S; Grzonka Z; Przybylski M
    J Med Chem; 2009 Apr; 52(8):2420-8. PubMed ID: 19317448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting protein-amyloid interactions with small molecules: a surface chemistry approach.
    Inbar P; Yang J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1076-9. PubMed ID: 16290147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.
    Zakaria A; Hamdi N; Abdel-Kader RM
    Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
    Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
    Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assay to screen for molecules that associate with Alzheimer's related beta-amyloid fibrils.
    Inbar P; Bautista MR; Takayama SA; Yang J
    Anal Chem; 2008 May; 80(9):3502-6. PubMed ID: 18380488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
    Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
    Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction.
    Morsy A; Maddeboina K; Gao J; Wang H; Valdez J; Dow LF; Wang X; Trippier PC
    ACS Chem Neurosci; 2022 Jul; 13(14):2176-2190. PubMed ID: 35802826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    He XY; Dobkin C; Brown WT; Yang SY
    J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
    Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
    Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.
    Valasani KR; Hu G; Chaney MO; Yan SS
    Chem Biol Drug Des; 2013 Feb; 81(2):238-49. PubMed ID: 23039767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.